VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.18−0.01 (-3.02%)
Close on Nov 18, 2026Market cap $2.50MP/E –Yield –
VolitionRx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
VolitionRx's revenue for the twelve months ending Jun 30, 2026 was $2.46M, up 86.3% year over year. For fiscal 2025 it was $1.73M, up 40.0% from the year before. The highest annual figure on record is $1.73M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.73M | +40.0% |
| FY2024 | Dec 31, 2024 | $1.23M | +59.1% |
| FY2023 | Dec 31, 2023 | $775.30K | +153.0% |
| FY2022 | Dec 31, 2022 | $306.39K | +240.3% |
| FY2021 | Dec 31, 2021 | $90.04K | +570.3% |
| FY2020 | Dec 31, 2020 | $13.43K | -21.4% |
| FY2019 | Dec 31, 2019 | $17.10K | +15.6% |
| FY2014 | Dec 31, 2014 | $14.79K | -73.1% |
| FY2012 | Dec 31, 2012 | $54.97K | – |
| FY2011 | Dec 31, 2011 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $398.66K | -2.0% |
| Q1 FY2026 | Mar 31, 2026 | $985.08K | +299.8% |
| Q4 FY2025 | Dec 31, 2025 | $447.03K | +133.2% |
| Q3 FY2025 | Sep 30, 2025 | $627.28K | +32.2% |
| Q2 FY2025 | Jun 30, 2025 | $406.69K | +2.8% |
| Q1 FY2025 | Mar 31, 2025 | $246.39K | +43.6% |
| Q4 FY2024 | Dec 31, 2024 | $191.66K | -21.4% |
| Q3 FY2024 | Sep 30, 2024 | $474.52K | +187.2% |
| Q2 FY2024 | Jun 30, 2024 | $395.80K | +83.0% |
| Q1 FY2024 | Mar 31, 2024 | $171.54K | +14.5% |
| Q4 FY2023 | Dec 31, 2023 | $243.97K | +103.8% |
| Q3 FY2023 | Sep 30, 2023 | $165.21K | +405.0% |
| Q2 FY2023 | Jun 30, 2023 | $216.31K | +444.1% |
| Q1 FY2023 | Mar 31, 2023 | $149.81K | +31.2% |
| Q4 FY2022 | Dec 31, 2022 | $119.72K | +740.7% |
| Q3 FY2022 | Sep 30, 2022 | $32.71K | +28.4% |
| Q2 FY2022 | Jun 30, 2022 | $39.75K | +60.4% |
| Q1 FY2022 | Mar 31, 2022 | $114.21K | +347.4% |
| Q4 FY2021 | Dec 31, 2021 | $14.24K | +100.0% |
| Q3 FY2021 | Sep 30, 2021 | $25.48K | +4331.8% |
| Q2 FY2021 | Jun 30, 2021 | $24.78K | +377.1% |
| Q1 FY2021 | Mar 31, 2021 | $25.53K | +4593.0% |
| Q4 FY2020 | Dec 31, 2020 | $7.12K | – |
| Q3 FY2020 | Sep 30, 2020 | $575 | -96.6% |
| Q2 FY2020 | Jun 30, 2020 | $5.19K | – |
| Q1 FY2020 | Mar 31, 2020 | $544 | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $17.10K | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
See a number that looks wrong?